Nanomedicine: Downsizing tumour therapeutics.
Christopher J
CJ
Cheng
W Mark
WM
Saltzman
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000098:blood supply* / Q000188:drug therapy*; D050997:Nanomedicine / Q000379:methods*; D053758:Nanoparticles
D020533:Angiogenesis Inhibitors